Ear drop ototoxicity: Reality or myth?

American Journal of Otology

Volumn 18, Issue 6, 1997, Pages 782-791

  Pickett, Bradley P ^a   Shinn, John B ^b   Smith, Mansfield F W ^b  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM ACETATE SOLUTION; AMPHOTERICIN B DEOXYCHOLATE; ANTIBIOTIC AGENT; AURALGAN; CHLORAMPHENICOL; CIPROFLOXACIN; CLOTRIMAZOLE; COLISTIN; CORTISPORIN; DESONIDE; DEXAMETHASONE PLUS TOBRAMYCIN; GENTAMICIN; NEOMYCIN; NYSTATIN; OTOCORT; POLYMYXIN B; SULFACETAMIDE; SULFAFURAZOLE; TOBRAMYCIN; TOLNAFTATE; TRIETHANOLAMINE OLEYLPOLYPEPTIDE; UNCLASSIFIED DRUG; VASOCIDIN; VOSOL;

DRUG FORMULATION; DRUG MONITORING; DRUG SAFETY; HUMAN; OTOTOXICITY; PERCEPTION DEAFNESS; PRIORITY JOURNAL; REVIEW;

ADRENAL CORTEX HORMONES; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; COCHLEAR DISEASES; HEARING LOSS, SENSORINEURAL; HUMANS; OTITIS MEDIA; ROUND WINDOW; SOLVENTS; SULFONAMIDES;

EID: 0030726037     PISSN: 01929763     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (81)

1. Rohn GN, Meyerhoff WL, Wright CG. Ototoxicity of topical agents. Otolaryngol Clin North Am 1993;26:747-58.
2. Waksman SA, Bugie E, Schatz A. Isolation of antibiotic substances from soil microorganisms with special reference to streptothricin and streptomycin. Proc Staff Meet Mayo Clin 1944;19:537-48.
3. Black FO, Pesznecker SC. Vestibular ototoxicity: clinical considerations. Otolaryngol Clin North Am 1993;26:713-36.
4. Hinshaw HC, Feldman WH. Streptomycin in treatment of clinical tuberculosis: a preliminary report. Proceedings of the Staff Meetings of the Mayo Clinic 1945;20:313-8.
5. Waksman SA, Lechavalier H, Harris DA. Neomycin- Production and Antibiotic Properties. J Clin Invest 1949;28:934-9.
6. Matz GJ. Aminoglycoside cochlear ototoxicity. Otolatyngol Clin North Am 1993;26:705-12.
7. Chambers HF, Sande MA. Antimicrobial Agents: The aminoglycosides. In: Goodman and Gillman's- The pharmacological basis of therapeutics. New York: McGraw Hill, 1996:1103-21.
8. Takeuchi T, Hikiti T, Nitta K. Studies on kanamycin. J Antibiot (Tokyo) 1957;10:107-14.
9. Higgins CC, Kastners RE. Nebramycin- a new broad spectrum antibiotic complex. II: Description of Streptomyces tenebrarius. Antimicrob Agents Chemother 1967;7:324-31.
10. Kawaguchi H, Naito J, Nakagawa S, et al. BB-K8: a new semisynthetic antibiotic. J Antibiot 1972;25:695-708.
11. Weinstein MJ, Leudemann GM, Oden EM, et al. Gentamicin: a new broad spectrum antibiotic complex. Antimicrob Agents Chemother 1963;3:1-7.
12. Brummett RE, Harris RF, Lindgren JA. Detection of ototoxicity from drugs applied topically to the middle ear space. Laryngoscope 1976;86:1177-87.
13. Mittelman H. Ototoxicity of "ototopical" antibiotics: past, present and future. Trans Am Acad Ophthalmol Otolaryngol 1972;76:1432-43.
14. Webster JC, McGee TM, Carroll R, et al. Ototoxicity of gentamicin: Histopathologic and functional results in the cat. Trans Am Acad Ophthalmol Otol 1970;74:1155-65.
15. Dayal VS, Smith EI, McCain G. Cochlear and vestibular gentamicin toxicity. Arch Otolaryngol 1974;100:338-40.
16. Fee WE. Aminoglycoside ototoxicity in the human. Laryngoscope 1980;24(Suppl):1-19.
17. Jongkees LBW, Hulk J. The action of streptomycin on vestibular function. Acta Otolaryngol 1950;38:225-32.
18. Morizono T, Johnstone BM. Ototoxicity of topically applied gentamicin using a statistical analysis of electrophysiological measurement. Acta Otolaryngol 1975;80:389-93.
19. Stupp H, Kupper K, Lagler R, et al. Inner ear concentrations and ototoxicity of different antibiotics in local and systemic application. Audiology 1973;12:350-63.
20. Murphy KW. Deafness after topical neomycin. Br Med J 1970;2:114.
21. Parker FL, James GW. The effect of various topical antibiotic and antibacterial agents on the middle and inner ear of the guinea-pig. J Pharm Pharmacol 1978;30:236-9.
22. Kohonen A, Tarkkanen J. Cochlear damage from ototoxic antibiotics by intratympanic application. Acta Otolaryngol (Stockh) 1969;68: 90-7.
23. Goycoolea MV, Muchow D, Schachern P. Experimental studies on round window structure: Function and permeability. Laryngoscope 1988;44(Suppl):1-20.
24. Nomura Y. Otological significance of the round window. In: Pfaltz CR, ed. Advances in oto-rhino-laryngology. New York: S Karger, 1984:1-162.
25. Paparella MM, Brady DR. Sensorineural hearing loss in chronic otitis media and mastoiditis. Trans Am Acad Ophthalmol Otolaryngol 1970;74:108-15.
26. Paparella MM, Morizono T, Le CT, et al. Sensorineural hearing loss in otitis media. Ann Otol Rhinol Laryngol 1984;93:623-9.
27. Tos M. Sensorineural hearing loss in acute and chronic middle ear diseases. Acta Otolaryngol Suppl 457 (Stockh) 1988:87-93.
28. Munker F. Inner ear hearing loss in acute and chronic otitis media. Adv Otorhinolaryngol 1981;27:138-43.
29. Moore DC, Best GF. A Sensorineural component in chronic otitis media. Laryngoscope 1980;90:1360-6.
30. Papastrovros T, Varlejides S. Reversible and permanent bone conduction threshold shift in cases of chronic suppurative otitis media. Am J Otol 1986;7:338-46.
31. English GM, Northern JL, Gria TJ. Chronic otitis media as a cause of Sensorineural hearing loss. Arch Otolaryngol 1973;98:18-22.
32. Cusimano F, Cocita VC, D'Amico A. Sensorineural hearing loss in chronic otitis media. J Laryngol Otol 1989;103:158-63.
33. Vartiainen E, Karjalainen S. Factors influencing Sensorineural hearing loss in chronic otitis media. Am J Otolaryngol 1987;8:13-5.
34. Noordzij JP, Dodson EE, Ruth RA, et al. Chronic otitis media and Sensorineural hearing loss: is there a clinically significant relation? Am J Otol 1995;16:420-3.
35. Levine BA, Shelton C, Berliner KI, et al. Sensorineural loss in chronic otitis media. Is it clinically significant? Arch Otolaryngol Head Neck Surg 1989;115:814-6.
36. Dumich PS, Harner SG. Cochlear function in chronic otitis media. Laryngoscope 1983;93:583-6.
37. Patterson WC, Gulick WL. The effects of chloramphenicol upon the electrical activity of the ear. Ann Otol Rhinol Laryngol 1963; 72:50-5.
38. Morizono T, Johnstone BM. Ototoxicity of chloramphenicol ear drops with propylene glycol as solvent. Med J Aust 1975;2:634-8.
39. Wersall J, Lundquist PG, Bjorkroth B. Ototoxicity of gentamicin. J Infect Dis 1969;119:410-5.
40. Webster JC, Carroll R, Benitez JT, et al. Ototoxicity of topical gentamicin in the cat. J Infect Dis 1971(Suppl):S138-44.
41. Smith BM, Myers MG. The penetration of gentamicin and neomycin into perilymph across the round window membrane. Otolaryngol Head Neck Surg 1979;87:888-91.
42. Morizono T, Johnstone. Ototoxicity of topically applied gentamicin using a statistical analysis of electrophysiological measurement. Acta Otolaryngol 1975;80:389-93.
43. Harada T, Iwamori M, Nagi Y, et al. Ototoxicity of neomycin and its penetration through the round window membrane into the perilymph. Ann Otol Rhinol Laryngol 1986;95:404-8.
44. Wright CG, Meyerhoff WL, Halama AR. Ototoxicity of neomycin and polymyxin B following middle ear application in the chinchilla and baboon. Am J Otol 1987;8:495-9.
45. Wright CG, Meyerhoff WL. Ototoxicity of otic drops applied to the middle ear in the chinchilla. Am J Otolaryngol 1984;5:166-7.
46. Wright CG, Halama AR, Meyerhoff WL. Ototoxicity of an ototopical preparation in a primate. Am J Otol 1987;8:56-60.
47. Meyerhoff WL, Morizono T, Wright CG, et al. Tympanostomy tubes and otic drops. Laryngoscope 1983;93:1022-7.
48. Morizono T. Toxicity of ototopical drugs: animal modeling. Ann Otol Rhinol Laryngol 1990;99:42-5.
49. Ikeda K, Morizono T. Round window membrane permeability during experimental purulent otitis media: altered Cortisporin ototoxicity. Ann Otol Rhinol Laryngol 1990;99:46-8.
50. Anderson RG, Wright CG, Meyerhoff WL. Inflammatory effects of otic drops on the middle ear. Int J Pediatr Otorhinolaryngol 1984;7:91-5.
51. Masaki M, Wright CG, Lee HL, et al. Effects of otic drops on chinchilla tympanic membrane. Arch Otolaryngol Head Neck Surg 1988;114:1007-11.
52. Brown OE, Wright CG, Meyerhoff WL. Ototoxicity of Vasocidin drops applied to the chinchilla middle ear. Arch Otolaryngol Head Neck Surg 1988;114:56-9.
53. Brownlee RE, Hulka GF, Prazma J, et al. Ciprofloxacin: use as a topical otic preparation. Arch Otolaryngol Head Neck Surg 1992;118:392-6.
54. Marsh RR, Tom LWC. Ototoxicity of antimycotics. Otolaryngol Head Neck Surg 1989;100:134-6.
55. Ikeda K, Morizono T. Effects of ototopic application of a corticosteroid preparation on cochlear function. Am J Otolaryngol 1991;12:150-3.
56. Spandow O, Anniko M, Hellstrom S. Hydrocortisone applied into the round window niche causes electrophysiological dysfunction of the inner ear. ORL. J Otorhinolaryngol Relat Spec 1989;51:94-102.
57. Morizono T, Paparella MM, Juhn SK. Ototoxicity of propylene glycol in experimental animals. Am J Otolaryngol 1980;1:393-9.
58. Vernon J, Brummett R, Walsh T. The ototoxic potential of propylene glycol in guinea pigs. Arch Otolaryngol 1978;104:726-9.
59. Vassalli L, Harris DM, Gradini R, et al. Inflammatory effects of topical antibiotic suspensions containing propylene glycol in chinchilla middle ears. Am J Otolaryngol 1988;9:1-5.
60. Masaki M, Wright CG, Lee DH, et al. Experimental cholesteatoma: Epidermal ingrowth through tympanic membrane following middle ear application of propylene glycol. Acta Otolaryngol (Stockh) 1989;108:113-21.
61. Morizono T, Sikora MA. Ototoxicity of ethanol in the tympanic cleft in animals. Acta Otolaryngol 1981;92:33-40.
62. Morizono T, Sikora MA. Compound action potential input-output derecruitment: Effect of topically applied antiseptics. Arch Otolaryngol 1983;109:677-81.
63. Morizono T, Sikora MA. The Ototoxicity of topically applied povidone-iodine preparations. Arch Otolaryngol 1982;108:210-3.
64. Schuknecht HF. Ablation therapy in the management of Ménière's disease. Acta Otolaryngol (Stockh) 1957;132(Suppl):1-39.
65. Morizono T. Ototopical agents: Ototoxicity in animal studies. Ann Otol Rhinol Laryngol 1988;131(Suppl):28-30.
66. Wright CG, Meyerhoff WL. Ototopical agents: efficacy or toxicity in humans. Ann Otol Rhinol Laryngol 1988;131(Suppl):30-2.
67. Matz GJ. Clinical perspectives on ototoxic drugs. Ann Otol Rhinol Laryngol 1990;99:39-41.
68. Fairbanks DNF. Pocket guide to antimicrobial therapy in otolaryngology-head and neck surgery. Alexandria, VA: The American Academy of Otolaryngology-Head and Neck Surgery Foundation, 1996:36-42.
69. Tommerup B, Moller K. A case of profound hearing impairment following the prolonged use of framycetin ear drops. J Laryngol Otol 1984;98:1135-7.
70. Podoshin L, Fradis M, Ben David J. Ototoxicity of ear drops in patients suffering from chronic otitis media. J Laryngol Otol 1989;103:46-50.
71. Linder TE, Zwicky S, Brändle P. Ototoxicity of ear drops: a clinical perspective. Am J Otol 1995;16:653-7.
72. Gydé MC. When the weeping stopped. An otologist views otorrhea and gentamicin. Arch Otolaryngol 1976;102:542-6.
73. Merifield DO, Parker NJ, Nicholson NC. Therapeutic management of chronic suppurative otitis media with otic drops. Otolaryngol Head Neck Surg 1993;109:77-82.
74. Esposito S, D'Errico G, Montanaro C. Topical and oral treatment of chronic otitis media with ciprofloxacin: a preliminary study. Arch Otolaryngol Head Neck Surg 1990;116:557-9.
75. Bicknell PG. Sensorineural deafness following myringoplasty operations. J Laryngol Otol 1971;85:957-61.
76. Lind O, Kristiansen B. Deafness after treatment with ear drops containing neomycin, gramicidin and dexamethasone. ORL J Otorhinolaryngol Relat Spec 1986;48:52-4.
77. Baker RS, Chole RA. A randomized clinical trial of topical gentamicin after tympanostomy tube placement. Arch Otolaryngol Head Neck Surg 1988;114:755-7.
78. Lundy LB, Graham MD. Ototoxicity and ototopical medications: a survey of otolaryngologists. Am J Otol 1993;14:141-6.
79. Physician's desk reference. New Jersey: Medical Economics Company, 1997.
80. Physician's desk reference for ophthalmology. New Jersey: Medical Economics Company, 1996.
81. Facts and comparisons: drug information. St. Louis: Wolters Kluwer Company, 1997.